TY - JOUR
T1 - Putrescine
T2 - A Novel Inhibitor of Glycosylation‐Induced Cross‐Links in Laniinin
AU - TSOPANOGLOU, NICOS E.
AU - ZIOUDROU, CHRISTINE
AU - Tsilibary, Effie-Photini C
AU - CHARONIS, ARISTIDIS S.
PY - 1995/9
Y1 - 1995/9
N2 - Objective: To determine whether putrescine, a naturally occuring polyamine, is able to prevent nonenzymatic glycosylation‐induced cross‐linking of basement membrane components. Cross‐linking, leading to the formation of advanced glycosylation end products (AGEs) has been proposed as a major mechanism contributing to structural and functional changes of the vascular wall, thus leading to microangiopathy. Methods: Laminin, a major basement membrane glycoprotein present in the microvasculature, was isolated and incubated in the presence of high glucose concentrations, in order to generate an in vitro diabetic environment. Putrescine was either present or absent from the incubation mixture. Formation of cross‐links was assessed by two independent methods: gel electrophoresis and development of characteristic fluorescence. Results: Putrescine inhibited in a dose‐dependent manner the formation of slower mobility bands in gel electrophoresis. Quantitation of the development of fluorescence characteristic of glycosylation‐induced cross‐links demonstrated that putrescine inhibited the formation of fluorescent products. Conclusions: Putrescine may be a promising compound for inhibition of protein cross‐linking and, therefore, could be used in the prevention of diabetic microangiopathy. 1995 Blackwell
AB - Objective: To determine whether putrescine, a naturally occuring polyamine, is able to prevent nonenzymatic glycosylation‐induced cross‐linking of basement membrane components. Cross‐linking, leading to the formation of advanced glycosylation end products (AGEs) has been proposed as a major mechanism contributing to structural and functional changes of the vascular wall, thus leading to microangiopathy. Methods: Laminin, a major basement membrane glycoprotein present in the microvasculature, was isolated and incubated in the presence of high glucose concentrations, in order to generate an in vitro diabetic environment. Putrescine was either present or absent from the incubation mixture. Formation of cross‐links was assessed by two independent methods: gel electrophoresis and development of characteristic fluorescence. Results: Putrescine inhibited in a dose‐dependent manner the formation of slower mobility bands in gel electrophoresis. Quantitation of the development of fluorescence characteristic of glycosylation‐induced cross‐links demonstrated that putrescine inhibited the formation of fluorescent products. Conclusions: Putrescine may be a promising compound for inhibition of protein cross‐linking and, therefore, could be used in the prevention of diabetic microangiopathy. 1995 Blackwell
KW - Microvasculature
KW - basement membrane
KW - diabetes
KW - nonenzymatic glycosylation
UR - http://www.scopus.com/inward/record.url?scp=0029365553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029365553&partnerID=8YFLogxK
U2 - 10.3109/10739689509146774
DO - 10.3109/10739689509146774
M3 - Article
C2 - 8748952
AN - SCOPUS:0029365553
VL - 2
SP - 283
EP - 287
JO - Microcirculation
JF - Microcirculation
SN - 1073-9688
IS - 3
ER -